Zhuang, J., Yu, Y., Li, Z., & Lu, S. (2017). Efficacy of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in targeted therapy of lung squamous cell carcinoma patients with EGFR mutation: A pooled analysis. Oncotarget.
Chicago Style CitationZhuang, Jingqi, Yongfeng Yu, Ziming Li, i Shun Lu. "Efficacy of Epidermal Growth Factor Receptor (EGFR)-tyrosine Kinase Inhibitors (TKIs) in Targeted Therapy of Lung Squamous Cell Carcinoma Patients With EGFR Mutation: A Pooled Analysis." Oncotarget 2017.
Cita MLAZhuang, Jingqi, Yongfeng Yu, Ziming Li, i Shun Lu. "Efficacy of Epidermal Growth Factor Receptor (EGFR)-tyrosine Kinase Inhibitors (TKIs) in Targeted Therapy of Lung Squamous Cell Carcinoma Patients With EGFR Mutation: A Pooled Analysis." Oncotarget 2017.